A. BÜYÜKCAM Et Al. , "Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey," HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.13, no.8, pp.1892-1894, 2017
BÜYÜKCAM, A. Et Al. 2017. Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey. HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.13, no.8 , 1892-1894.
BÜYÜKCAM, A., Güdücüoğlu, H., Karaman, K., Gurbuz, V., Aliyev, E., KARA, A., ... CEYHAN, M.(2017). Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey. HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.13, no.8, 1892-1894.
BÜYÜKCAM, AYŞE Et Al. "Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey," HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.13, no.8, 1892-1894, 2017
BÜYÜKCAM, AYŞE Et Al. "Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey." HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.13, no.8, pp.1892-1894, 2017
BÜYÜKCAM, A. Et Al. (2017) . "Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey." HUMAN VACCINES & IMMUNOTHERAPEUTICS , vol.13, no.8, pp.1892-1894.
@article{article, author={AYŞE BÜYÜKCAM Et Al. }, title={Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey}, journal={HUMAN VACCINES & IMMUNOTHERAPEUTICS}, year=2017, pages={1892-1894} }